ConductScience.org, home

Paper25354682

Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.

Lai YH and 3 others. Gene Ther, 2015. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors. Papers, record 25354682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25354682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.
PubMed
Journal
Gene Ther
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2026-08-06
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lai YHY-H
2Lin CCC-Chttps://orcid.org/0000-0003-3843-4333
3Chen SHS-H
4Tai CKC-K

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Leukemia Virus, MurineMajor topic
Liver Neoplasms, ExperimentalMajor topic
Animals
Base Sequence
Genetic Therapy
Genetic Vectors
Genomic Instability
Green Fluorescent Proteins
HEK293 Cells
Hep G2 Cells
Humans
MCF-7 Cells
Mice, Inbred BALB C
Mice, Nude
Molecular Sequence Data
Neoplasm Transplantation
Promoter Regions, Genetic
Terminal Repeat Sequences
Transcription, Genetic
Virus Replication
alpha-Fetoproteins

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19396605Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.Nat Med1997https://conductscience.org/library/papers/9396605PubMed
29634004Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells.Biochem Pharmacol1998https://conductscience.org/library/papers/9634004PubMed
31838933Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.Hum Gene Ther1991https://conductscience.org/library/papers/1838933PubMed
418509380Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue.Gene Ther2008https://conductscience.org/library/papers/18509380PubMed
59080121Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.Cancer Gene Ther1997https://conductscience.org/library/papers/9080121PubMed
612728277Progress and problems with the use of viral vectors for gene therapy.Nat Rev Genet2003https://conductscience.org/library/papers/12728277PubMed
724825189MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response.Hum Gene Ther2014https://conductscience.org/library/papers/24825189PubMed
87645245Effects of adoptive immune transfers on murine leukemia virus-infection of rats.Virology1995https://conductscience.org/library/papers/7645245PubMed
91317968In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.Science1992https://conductscience.org/library/papers/1317968PubMed
102370865Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Mol Cell Biol1990https://conductscience.org/library/papers/2370865PubMed
1111096443
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
Hum Gene Ther2000https://conductscience.org/library/papers/11096443PubMed
1220467451Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.Cancer Gene Ther2010https://conductscience.org/library/papers/20467451PubMed
131699279Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.Semin Oncol1990https://conductscience.org/library/papers/1699279PubMed
1415374975Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.Cancer Res2004https://conductscience.org/library/papers/15374975PubMed
152427240Pharmacokinetic study of fludarabine phosphate (NSC 312887).Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/2427240PubMed
169195219Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors.Hum Gene Ther1997https://conductscience.org/library/papers/9195219PubMed
1711435579Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.J Virol2001https://conductscience.org/library/papers/11435579PubMed
1817981778Replication-competent retrovirus vectors for cancer gene therapy.Front Biosci2008https://conductscience.org/library/papers/17981778PubMed
193031469Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.Mol Cell Biol1987https://conductscience.org/library/papers/3031469PubMed
209824049Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.Cancer Gene Ther1998https://conductscience.org/library/papers/9824049PubMed

See all 45 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42325780Serum alpha-fetoprotein kinetics as a mechanistic biomarker for rAAV-TK/GCV efficacy in hepatocellular carcinoma.Am J Transl Res2026https://conductscience.org/library/papers/42325780PubMed
32085552Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32085552PubMed
31769427Gene Therapy for Liver Cancers: Current Status from Basic to Clinics.Cancers (Basel)2019https://conductscience.org/library/papers/31769427PubMed
30160343H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma.J Cell Mol Med2018https://conductscience.org/library/papers/30160343PubMed
29563582Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma.Gene Ther2018https://conductscience.org/library/papers/29563582PubMed
27843535Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention.World J Hepatol2016https://conductscience.org/library/papers/27843535PubMed
26648599Tissue Specific Promoters in Colorectal Cancer.Dis Markers2015https://conductscience.org/library/papers/26648599PubMed
26077653Management strategies for hepatocellular carcinoma: old certainties and new realities.Clin Exp Med2016https://conductscience.org/library/papers/26077653PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25354682

GET https://conductscience.org/api/papers/v1/25354682/references?page=2